Tilray Brands (TLRY) Projected to Post Quarterly Earnings on Tuesday

Tilray Brands (NASDAQ:TLRY) is expected to issue its Q4 2026 results after the market closes on Tuesday, July 28th. Analysts expect Tilray Brands to announce earnings of ($0.01) per share and revenue of $249.6420 million for the quarter. Investors can check the company’s upcoming Q4 2026 earning report for the latest details on the call scheduled for Tuesday, July 28, 2026 at 4:30 PM ET.

Tilray Brands Price Performance

NASDAQ TLRY opened at $4.23 on Tuesday. The stock’s 50-day moving average price is $4.90 and its two-hundred day moving average price is $6.56. The company has a current ratio of 2.79, a quick ratio of 1.66 and a debt-to-equity ratio of 0.19. The company has a market cap of $493.01 million, a PE ratio of -0.31 and a beta of 1.89. Tilray Brands has a 1 year low of $4.20 and a 1 year high of $23.20.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on TLRY. Weiss Ratings downgraded shares of Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Roth Capital upgraded shares of Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a research report on Thursday, April 2nd. ATB Cormark Capital Markets decreased their price objective on shares of Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating for the company in a research note on Thursday, April 2nd. Finally, TD Cowen lowered their price objective on shares of Tilray Brands from $7.00 to $5.00 and set a “buy” rating on the stock in a research report on Tuesday, July 14th. Three research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Tilray Brands presently has a consensus rating of “Hold” and a consensus price target of $11.00.

Hedge Funds Weigh In On Tilray Brands

Institutional investors and hedge funds have recently bought and sold shares of the business. AQR Capital Management LLC increased its holdings in shares of Tilray Brands by 1,839.7% in the 1st quarter. AQR Capital Management LLC now owns 607,054 shares of the company’s stock valued at $399,000 after purchasing an additional 575,757 shares during the period. XTX Topco Ltd purchased a new stake in shares of Tilray Brands in the second quarter worth approximately $112,000. Cerity Partners LLC boosted its holdings in shares of Tilray Brands by 98.5% during the second quarter. Cerity Partners LLC now owns 92,560 shares of the company’s stock worth $38,000 after purchasing an additional 45,929 shares during the period. Ausdal Financial Partners Inc. acquired a new stake in shares of Tilray Brands during the second quarter worth approximately $939,000. Finally, Bank of America Corp DE grew its position in Tilray Brands by 26.5% during the second quarter. Bank of America Corp DE now owns 311,810 shares of the company’s stock valued at $129,000 after purchasing an additional 65,379 shares in the last quarter. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.